2017
DOI: 10.3103/s0096392518010066
|View full text |Cite
|
Sign up to set email alerts
|

Secretion of Proteinases with Fibrinolytic Activity by Micromycetes of the Genus Aspergillus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Micromycete A. terreus 2 is a producer of extracellular proteolytic enzymes capable of activating prekallikrein via its limited proteolysis and possessing plasmin-like activity. Previous studies of A. terreus 2 were the first to show that extracellular proteases produced by micromycetes are able to activate prekallikrein in human blood plasma, and also established that proteases of micromycetes are also capable to hydrolyze both fibrin and fibrinogen [5,9,16,17]. Activation of prekallikrein makes it possible to consider the protease of this micromycete as a potential diagnostic component for quantity determining of the specified protein in the blood plasma of patients, and the fibrinolytic effect may indicate a potential use as a treatment for superficial microthrombosis and bruising.…”
Section: Introductionmentioning
confidence: 99%
“…Micromycete A. terreus 2 is a producer of extracellular proteolytic enzymes capable of activating prekallikrein via its limited proteolysis and possessing plasmin-like activity. Previous studies of A. terreus 2 were the first to show that extracellular proteases produced by micromycetes are able to activate prekallikrein in human blood plasma, and also established that proteases of micromycetes are also capable to hydrolyze both fibrin and fibrinogen [5,9,16,17]. Activation of prekallikrein makes it possible to consider the protease of this micromycete as a potential diagnostic component for quantity determining of the specified protein in the blood plasma of patients, and the fibrinolytic effect may indicate a potential use as a treatment for superficial microthrombosis and bruising.…”
Section: Introductionmentioning
confidence: 99%